BNS003

BNS003 is a small molecule drug developed by Boehringer Ingelheim. It has been investigated primarily for the treatment of symptoms associated with venous insufficiency and disorders of leg venous reflux, such as swelling, heaviness, tiredness (dullness), tension, tingling, pain, fever, or itching in the calf and ankle. Clinical studies have focused on its efficacy and safety in alleviating these subjective symptoms related to impaired venous return in the lower extremities. There are also references to research into neurological therapeutic applications (including anxiety, depression, and cognitive disorders), but its main clinical development has centered on vascular indications[1][2][3][4][5][7].